BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220905
DTEND;VALUE=DATE:20220908
DTSTAMP:20260415T072252
CREATED:20220630T114607Z
LAST-MODIFIED:20220630T114607Z
UID:19633-1662336000-1662595199@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: City of Mentor\, Ohio - Fifth Annual Conference on Innovation & Trade
DESCRIPTION:  \nThe Northeast Ohio region is home to some of the leading medical institutions in the United States\, including the Cleveland Clinic\, and the region has developed one of the nation’s most important biomedical clusters. \nThe City of Mentor\, Ohio is pleased to offer you this opportunity to learn more about the advantages of doing business in Northeast Ohio and the City of Mentor\, particularly in the healthcare industry\, through the 5th Annual Conference on Innovation and Trade. Over 700 biomedical firms are located here\, including over 400 medical device manufacturers specializing in imaging\, neurostimulation\, orthopedics\, cardiovascular\, and sterilization. Among these are world leaders such as General Electric Healthcare\, Siemens\, Toshiba\, Hitachi\, Philips Healthcare\, and STERIS. \nOhio’s commitment to supporting investment in the biotech industry and these centers of excellence and innovation have driven Ohio’s biomedical industry to grow by 59% since the year\n2000\, now employing over 80\,000 experienced workers. Mentor\, Ohio is strategically located in the heart of this cluster and ready to assist international biomedical and technical companies\nto invest for success. \nThis three-day conference includes a packed programme of keynote talks\, seminars\, informal networking opportunities and an evening reception. \nFor more information on how Medilink Midlands can support your attendance at this conference\, please get in touch. \nTo learn more about the City of Mentor International Conference on Innovation and Trade and to register for additional information\, please click here. Booking details can be found here.
URL:https://staging.medilinkmidlands.com/event/city-of-mentor-fifth-annual-conference/
LOCATION:City of Mentor\, Ohio
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220905T130000
DTEND;TZID=Europe/London:20220905T150000
DTSTAMP:20260415T072252
CREATED:20220818T123926Z
LAST-MODIFIED:20220818T124424Z
UID:20017-1662382800-1662390000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: BBSRC/DEFRA Endemic Livestock Diseases Programme
DESCRIPTION:The BBSRC are offering two informative webinars to coincide with the Phase 2 launch of the BBSRC/DEFRA Endemic Livestock Diseases. These sessions offer the chance for those interested in applying for the funding to learn more about the opportunity and to pose their questions to those allocating the funds. \nBook your place today\nBBSRC/DEFRA Endemic Livestock Diseases Programme  \nThe Endemic Livestock Diseases Initiative aims to meaningfully reduce the overall level and impact of endemic disease on the UK livestock sector\, to improve productivity and the health and welfare of animals. The initiative will bring academia and businesses together to co-create novel prevention and intervention solutions. \nAll projects must include at least one business project partner. The full economic cost of your project can be up to £1\,000\,000 over 3 years. BBSRC will fund 80% of the full economic cost. The business project partner must contribute at least 10% cash (or in-kind) of the full economic cost of the project. \nProject collaborators are crucial participants in the proposals. They may encompass a wide range of stakeholders\, including: \n\nfarmers\nbusinesses\ninnovators\nveterinary practitioners\ndata management service providers\n\nBusinesses must be UK-based or have UK-based research activity. \nProjects should address the themes below. The scope is solutions-focused and research and translation activities that cut across the themes are encouraged. \n\nDigital agriculture\nGenetics and breeding\nFarm management\nVaccine platforms and technologies\nNovel therapeutics\nCo-infection\n\nExclusions from this call include bovine TB and animal nutrition. \nFor more information about the initiative\, click here.
URL:https://staging.medilinkmidlands.com/event/webinar-bbsrc-defra-endemic-livestock-diseases-programme-2/
LOCATION:Online
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220907T100000
DTEND;TZID=Europe/London:20220907T113000
DTSTAMP:20260415T072252
CREATED:20220725T145156Z
LAST-MODIFIED:20220905T111549Z
UID:19795-1662544800-1662550200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: 3D Printing in Healthcare
DESCRIPTION:  \nThe next webinar in the Additive Manufacturing Special Interest Group series is taking place on Wednesday 7th September. The session will focus on the latest innovations and developments in 3D Printing across the healthcare sector. Chaired by Ruth Goodridge\, our programme includes talks from: \n\nSophie Cox\, Associate Professor in Healthcare Technologies\, University of Birmingham\nHenry Pinchbeck\, CEO\, 3D Lifeprints\nPeter Llewelyn Evans\, Maxillofacial Laboratory Services Manager\, Swansea Bay UHB.\n\nSee below for speaker profiles and presentation titles \nBOOK YOUR FREE PLACE\nSpeaker Profiles \n \nHenry Pinchbeck\, CEO\, 3D LifePrints \nPresentation title: Personalising Surgery: Medical 3D printing at the Point of Care \n3D LifePrints is a leading Personalised Surgery and Medical 3D Printing company. Its focus is the design and manufacture of patient specific medical devices. 3D LifePrints’ USP is that it provides its services from embedded facilities at the Point of Care within host hospitals\, allowing the clinicians direct access to the full range of 3D technologies. 3D LifePrints recently opened its first facility in the USA\, at the Texas Medical Center. Henry Pinchbeck is a Founder and the CEO of 3D LifePrints. A scientist by training\, he is an experienced businessman and a UK qualified solicitor. As CEO\, Henry is responsible for all 3D LifePrints’ global activities but particularly concentrates on the development of the medical 3D printing sector in the UK and USA. \n# \nPeter Llewelyn Evans\, Maxillofacial Laboratory Services Manager\, Maxillofacial Laboratory \nPresentation title: The Application of 3D Printing in Head and Neck Reconstruction \nPeter’s career started studying Maxillofacial Prosthetics in London in 1987. He moved to South Wales to join the Welsh Craniofacial Implant Team in 1989\, a team that pioneered the use of Craniofacial Implants at St Lawrence Hospital\, Chepstow. The Unit relocated to Morriston Hospital\, Swansea in 1998 where he is the manager of the Maxillofacial Laboratory Services. \nHis main areas of interest include facial prosthetics for children\, craniofacial implantology and 3D modelling and imaging. He has published extensively on the use of digital technology in Maxillofacial surgery and technology and in particular on the integration of digital technologies into facial prosthetics. Peter has also lectured in the UK and worldwide. \nPeter is a fellow of the IMPT\, founder member of the British Facial and Audiological Implant Group (BFAIG)\, a founder member and Secretary of  the Centre for Applied Technology in Surgery (CARTIS) and Secretary to the Advanced Digital Technologies (ADT) Foundation. \n \nDr Sophie Cox\, Associate Professor in Healthcare Technologies\, University of Birmingham \nPresentation title: Moving additive manufacturing beyond anatomically customised implants \nSophie is an Associate Professor in healthcare technologies at the University of Birmingham and leads the Centre for Custom Medical Devices. Her research focuses on exploiting additive manufacturing for the production of personalised metallic implants to replace or regenerate skeletal tissues. The team predominantly works on developing strategies to add functionality through surface modification or modification of device designs. In this talk she shall share three case studies to highlight that we may merge the design freedoms of 3d printing with biomaterials advancements to move custom medical devices into a new era that delivers additional patient benefits. \nThis free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to the region and is open to all. \nDURATION: 1.5 hours \n 
URL:https://staging.medilinkmidlands.com/event/webinar-3d-printing-in-healthcare/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220912T080000
DTEND;TZID=Europe/London:20220912T170000
DTSTAMP:20260415T072252
CREATED:20220617T100704Z
LAST-MODIFIED:20220617T100704Z
UID:19480-1662969600-1663002000@staging.medilinkmidlands.com
SUMMARY:In-person event: MedTech Integrates 2022
DESCRIPTION:*Please note that this event has been rescheduled from 21st June 2022. See bottom of this page for note from organisers regarding tickets already booked.*\n  \nFocused on technology\, diagnostics\, devices\, therapeutics organisations\, and regulators\nInspired by the success of this year’s MedTech Integrates in June 2021\, Life Science Integrates is delighted to announce the third MedTech Integrates conference. This one-day gathering of technology\, diagnostics\, devices and therapeutics organisations\, as well as clinicians and regulators\, provides a platform to discuss the major challenges impacting the MedTech sector. \nAddressing the needs of the MedTech community to overcome the challenges needed to achieve a transformation of diagnostics and devices in healthcare\, MedTech Integrates will be to a face-to-face one-day conference\, taking place at the Leonardo Royal Hotel London Tower Bridge on 12 September 2022. \nTo view the full programme and to book your place\, click here.\n  \nNote from organisers: \nAs you are no doubt aware\, the RMT have planned a number of rail and tube strikes in June; the first of which is planned for 12 September\, the date of MedTech Integrates. If this strike goes ahead\, we realise the impact this would have for our delegates\, speakers\, sponsors and innovators. \nAs such\, we have taken the very difficult decision to postpone the event until Monday 12 September (at the same venue). Please note: \nAll tickets will remain valid and we will transfer these to 12 September. \nThere are no changes to the agenda timings or session content. \nWe apologise for the inconvenience\, which is of course out of our immediate control. Please rest assured we took this decision to ensure as little disruption as possible and that MedTech Integrates 2022 remains a hugely successful event.
URL:https://staging.medilinkmidlands.com/event/in-person-event-medtech-integrates-2022/
LOCATION:Leonardo Royal Hotel\, London Tower Bridge
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220914T093000
DTEND;TZID=Europe/London:20220914T130000
DTSTAMP:20260415T072252
CREATED:20220725T144104Z
LAST-MODIFIED:20220907T155308Z
UID:19791-1663147800-1663160400@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Infection Control: What has Covid taught us?
DESCRIPTION:**PLEASE NOTE THAT THIS EVENT WILL NOW BE HELD ONLINE**\nThe latest session in the Infectious Diseases Special Interest Group (SIG) series is taking place on Wednesday 14 September. Organised in partnership with De Montfort University\, the session will be chaired by Dr Maitreyi Shivkumar\, Senior Lecturer in Molecular Biology at the Leicester School of Pharmacy\, and will include three presentations from our expert panel (see programme and speaker profiles below for full details). \nTo book your free spot at this ONLINE event\, please click here.\nSpeakers and presentation titles \n \nDr Maitreyi Shivkumar\, Senior Lecturer in Molecular Biology\, School of Pharmacy\, De Montfort University \nSession Chair \nMaitreyi Shivkumar is a Senior Lecturer in Molecular Biology in the School of Pharmacy at De Montfort University. Her research interests are in developing novel antivirals and understanding host-virus interactions\, with a focus on coronaviruses and HIV. She has also developed coronavirus models and systems to evaluate environmental stability and antiviral efficacy of disinfectants against human coronaviruses. \n  \n \nDr Enrico Ferrari\, Senior Lecturer in Biotechnology\, School of Life Sciences\, University of Lincoln \nPresentation title: The mechanism of adsorption of SARS-CoV-2 spike protein onto solid materials: Can new knowledge contribute to infection control? \nEnrico studied for his BSc+MSc in Biotechnology at the University of Udine\, Italy between 1996 and 2001. He subsequently completed a PhD in Nanotechnology\, graduating from the University of Trieste\, Italy in 2007. Enrico went on the undertake a Postdoc in Biophotonics from 2007 to 2009 at CNR\, Trieste\, Italy\, followed by a Postdoc in Molecular Neurobiology between 2009 and 2012 at the MRC Laboratory of Molecular Biology\, Cambridge\, UK. He joined University of Lincoln’s School of Life Sciences in 2012\, where he is currently a Senior Lecturer in Biotechnology. Enrico primarily studies the mechanism of interaction between biomolecules and nanoparticles and applies this knowledge to the field of nanobiotechnology. \n  \n \nDr Gracy Sailo-Lebeau\, Director of Technical Projects and Head of R&D\, Residual Barrier Technology Ltd \nPresentation title: Are biodegradable disinfectants effective against dry surface biofilms and multi drug resistant bacteria? \nGracy oversees the R&D department at Residual Barrier Technology where I take the lead role in new and innovative product development from concept to launch. Gracy has a BSc in Plant Pathology and MSc in Agricultural Microbiology\, and obtained a PhD in Environmental Microbiology at Coventry University in 2008. As a Post-Doctoral Research Fellow\, Gracy investigated the antimicrobial properties of plants and chemicals and have since worked in commercial research\, new disinfectant development\, regulatory affairs\, infection control and hygiene related areas. \n \nSiobhan Murphy\, Regulatory Specialist\, Contec Cleanroom Ltd. \nPresentation Title: EU and GB Biocidal Products Regulation – A Post-Brexit Update \nSiobhan is a Regulatory Specialist with over 10 years experience in the field of chemical regulations\, primarily biocidal product legislation. Having previously worked as a consultant\, Siobhan joined Contec in April 2018 to manage the authorisation of their cleanroom disinfectants in the EU\, GB and global markets. \n*** \nThis free-to-attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. \nPlease note: whilst this event is held as part of the SoLSTICE programme\, attendance is not restricted to companies in the Leicester/Leicestershire area and is open to all.
URL:https://staging.medilinkmidlands.com/event/in-person-event-disinfectants-state-of-the-art-and-the-regulatory-landscape/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220914T093000
DTEND;TZID=Europe/London:20220914T144500
DTSTAMP:20260415T072252
CREATED:20220726T082924Z
LAST-MODIFIED:20220831T150049Z
UID:19803-1663147800-1663166700@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Engaging with MedTech and HealthTech to support SMEs
DESCRIPTION:The DEMAND Hub (Data-Enabled Medical technologies and Devices Hub)\, brought to you by the University of Birmingham\, is delighted to bring you this SME engagement event that will provide support to small to medium sized enterprises (SMEs) to access the right expertise that will enable them to successfully collaborate and move novel ideas from products and services through to apps and data technologies. \nThe event will provide delegates with an opportunity to engage with experts working within the field of medical innovation translation – including representatives from Medilink Midlands – and will focus on how collaboration is key for the success of these innovations from the laboratory through to the clinic and towards commercial exploitation. \nThe event will also offer a unique pitching opportunity for SMEs to receive 1-to-1 coaching from experts working within the field of commercialisation and technology translation. \nFor more information and to book your spot\, click here.
URL:https://staging.medilinkmidlands.com/event/in-person-event-engaging-with-medtech-and-healthtech-to-support-smes/
LOCATION:Edgbaston Park Hotel and Conference Centre\, 53 Edgbaston Park Road\, Birmingham\, B15 2RS
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220915
DTEND;VALUE=DATE:20220917
DTSTAMP:20260415T072252
CREATED:20220825T104359Z
LAST-MODIFIED:20220825T104359Z
UID:20115-1663200000-1663372799@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: 7th Molecular Microbiology Conference
DESCRIPTION:The 7th Molecular Microbiology conference\, sponsored by AltaBioscience\, will take place at the University of Birmingham\, UK on 15th – 16th September 2022. This event is a fantastic opportunity to hear about cutting-edge research in microbiology from leading UK and international researchers with talks and posters covering the latest trends on interactions between microbes and their environment\, gene expression and RNA biology\, bacterial cell structures\, replication and cell division\, and human pathogens. \nFor more information and to book your place\, click here. \nAbout the Molecular Microbiology (Mol Micro) Conference\nThe Conference was first organised by Jörg Vogel (University of Würzburg) and John Helmann (Cornell University) eleven years ago (https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2958.2011.07852.x).   It celebrates the journal of the same name that has long been a gold standard for publishing in the field. Speakers are drawn from the journal’s recent authors and it also provides opportunities for early career researchers to present their work. \nConfirmed speakers:\n\nJulia van Kessel: Indiana State University (USA) \nTom Santangelo: Colorado State University (USA) \nThorsten Mascher: Technical University of Dresden (Germany) \nKlas Flardh: Lund University (Sweden) \nAngelika Gründling (Imperial College London) \nKristina Jonas: Stockholm University (Sweden) \nDirk Schüler: University of Bayreuth (Germany)  \nEva Frickel (University of Birmingham (UK) \n\nThe full schedule can be found here. \nConference fees and booking:\nStandard registration ends 26th August 2022. \nStudent rate:\n\nEarly bird: £100 (EXTENDED UNTIL 20th May 2022)\nRegular rate: £200 (after 20th May 2022)\n\nAcademic/Professional rate:\n\nEarly bird: £150 (EXTENDED UNTIL 20th May 2022)\nRegular: £250 (after 20th May 2022)
URL:https://staging.medilinkmidlands.com/event/in-person-event-7th-molecular-microbiology-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220929T080000
DTEND;TZID=Europe/London:20220929T170000
DTSTAMP:20260415T072252
CREATED:20220929T123334Z
LAST-MODIFIED:20220929T123334Z
UID:20648-1664438400-1664470800@staging.medilinkmidlands.com
SUMMARY:ONLINE EVENT: NHS Scan4Safety Healthcare Supplier Forum
DESCRIPTION:This is a live virtual forum delivered via Zoom on Wednesday 12 October 2022 from 10:00am–1:30pm. \nJoin us for this online forum to hear from leaders in England\, Scotland and Wales about their plans to use open global standards to improve patient safety and supply chain processes for their Scan4Safety programmes. \nHear the latest from the Medicines and Healthcare products Regulatory Agency (MHRA) about the future regulation of medical devices. \nNHS Supply Chain will also be presenting on their strategy and the continued adoption of GS1 standards. \nThere will also be presentations from suppliers that have implemented GS1 standards for UDI. \nFor more information and to book your place\, click here.
URL:https://staging.medilinkmidlands.com/event/online-event-nhs-scan4safety-healthcare-supplier-forum/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220929T140000
DTEND;TZID=Europe/London:20220929T150000
DTSTAMP:20260415T072252
CREATED:20220922T144243Z
LAST-MODIFIED:20220922T144243Z
UID:20581-1664460000-1664463600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: An Overview of the Future UK Medical Device Regulation
DESCRIPTION:SEHTA are pleased to offer you a FREE to attend webinar session with IVDeology on an overview of the main points from the UK government’s response to consultation on the future UK Medical Device Regulation. \nOverview of Webinar \nA chance for attendees to listen to an appraisal of the government’s responses to the consultation results around the shape of the UK Medical Device Regulations going forward. \nWe will review the UKRP requirements with the Quality Person role\, classification proposals\, transition provisions to name a few. \nThere will be ample opportunity for questions at the end of the presentation. \nSpeaker profile: Stuart Angell\, Managing Director & Co-founder\, IVDeology \nStuart created IVDeology to provide clear\, pragmatic advice and support to the IVD industry focusing on small and mid-size businesses who may not be so familiar with the requirements of IVD regulations in the UK\, EU and the rest of the world. \nIVDeology is a well established and growing UK company providing quality and regulatory consultancy\, training and compliance services to the IVD industry. \nClick here for more details and to register.
URL:https://staging.medilinkmidlands.com/event/webinar-an-overview-of-the-future-uk-medical-device-regulation/
END:VEVENT
END:VCALENDAR